Related references
Note: Only part of the references are listed.CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ+CD8+T Cells and Modest Inhibition of Neuroinflammation
James M. Nichols et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Spinal astroglial cannabinoid receptors control pathological tremor
Eva Maria Meier Carlsen et al.
NATURE NEUROSCIENCE (2021)
Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis
Karan Mathur et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Effects of O-1602 and CBD on TNBS-induced colonic disturbances
DanDan Wei et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Mikiei Tanaka et al.
FRONTIERS IN NEUROLOGY (2020)
Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation
Xiaoming Yang et al.
JOURNAL OF IMMUNOLOGY (2020)
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression
Amira Mohammed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production
William Becker et al.
ISCIENCE (2020)
IL-17A brings new recruits to EAE
Kirsty Minton
NATURE REVIEWS IMMUNOLOGY (2020)
Immune Responses Regulated by Cannabidiol
James M. Nichols et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1
Yan Li et al.
AUTOPHAGY (2019)
Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
Marco Gentili et al.
PHARMACOLOGICAL RESEARCH (2019)
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
Zinah Zamil Al-Ghezi et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells
Emeka B. Okeke et al.
FRONTIERS IN IMMUNOLOGY (2019)
Molecular mechanism of TRPV2 channel modulation by cannabidiol
Ruth A. Pumroy et al.
ELIFE (2019)
Combination of Cannabinoids, Δ9-Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Zinah Zamil Al-Ghezi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Synthetic Strategies for (-)-Cannabidiol and Its Structural Analogs
Byunghyuck Jung et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
Xiaoming Yang et al.
SCIENTIFIC REPORTS (2019)
The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
Misagh Rajabinejad et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation
Gemma Manich et al.
NEUROSCIENCE (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Cannabinoid Ligands Targeting TRP Channels
Chante Muller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Chromatin dependencies in cancer and inflammation
Ivan Marazzi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
Giulia Donvito et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production
Hsin-Ying Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
Miriam Mecha et al.
GLIA (2018)
Hepatitis B virus sensitivity to interferon- in hepatocytes is more associated with cellular interferon response than with viral genotype
Fang Shen et al.
HEPATOLOGY (2018)
Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
Aoife M. McGinley et al.
JOURNAL OF AUTOIMMUNITY (2018)
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Yong Wang et al.
JOURNAL OF IMMUNOLOGY (2018)
The inhibition of CB1 receptor accelerates the onset and development of EAE possibly by regulating microglia/macrophages polarization
Lou Zhi-Yin et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
Tanbeena Imam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
David M. Elliott et al.
FRONTIERS IN IMMUNOLOGY (2018)
Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
Erhei Dai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
Thais Barbosa Alberti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
Taku Kuwabara et al.
MEDIATORS OF INFLAMMATION (2017)
Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria
Dana Balitzer et al.
MODERN PATHOLOGY (2017)
Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
Zhongliang Shen et al.
NATURE COMMUNICATIONS (2017)
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
Saphala Dhital et al.
CELLULAR IMMUNOLOGY (2017)
Diet, Nutrition, and Cancer Epigenetics
Carmen Sapienza et al.
ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)
Epigenetic Effects of Cannabis Exposure
Henrietta Szutorisz et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
Sindiswa T. Lukhele et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Polypharmacological Properties and Therapeutic Potential of beta-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Charu Sharma et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection
Nicola Coppola et al.
DIGESTIVE AND LIVER DISEASE (2016)
RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation
Xiaoming Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
Jessica M. Sido et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling
Anna Chiarlone et al.
NEUROPHARMACOLOGY (2016)
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
Anne Kerbrat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
Urs Christen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Δ9Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
R. Rao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
Edith Hochhauser et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans
Chengrui Huang et al.
GASTROENTEROLOGY (2015)
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
Venkatesh L. Hegde et al.
JOURNAL OF IMMUNOLOGY (2015)
Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice
Yen-Lin Huang et al.
NATURE COMMUNICATIONS (2015)
Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners
Hong Lei et al.
FRONTIERS IN PHARMACOLOGY (2015)
MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins
Haein Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques
Lawrance C. Chandra et al.
JOURNAL OF VIROLOGY (2015)
Endogenous Interferon-beta-Inducible Gene Expression and Interferon-beta-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
Lars Boernsen et al.
PLOS ONE (2015)
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation
Eu Jin Lim et al.
PLOS ONE (2015)
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
Weimin Kong et al.
CELLULAR IMMUNOLOGY (2014)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young-Suk Lim et al.
GASTROENTEROLOGY (2014)
IFNG rs1861494 Polymorphism Is Associated with IBD Disease Severity and Functional Changes in Both IFNG Methylation and Protein Secretion
Rivkah Gonsky et al.
INFLAMMATORY BOWEL DISEASES (2014)
Histone Modifications Are Associated with Δ9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses
Xiaoming Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1
Austin R. Jackson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
Yawei Liu et al.
NATURE MEDICINE (2014)
β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
Amine Bahi et al.
PHYSIOLOGY & BEHAVIOR (2014)
Anandamide Attenuates Th-17 Cell-Mediated DelayedType Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
Austin R. Jackson et al.
PLOS ONE (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis
Hongbing Guan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Distinct MicroRNA Expression Profile and Targeted Biological Pathways in Functional Myeloid-derived Suppressor Cells Induced by Δ9-Tetrahydrocannabinol in Vivo
Venkatesh L. Hegde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The role of CB1 in immune modulation by cannabinoids
Barbara L. F. Kaplan
PHARMACOLOGY & THERAPEUTICS (2013)
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
Sergiy Sylantyev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Δ8-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: Involvement of cannabinoid receptor 2 and p38 MAPK
Satoshi Yamaori et al.
TOXICOLOGY (2013)
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
D. Vara et al.
CELL DEATH & DISEASE (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
J. C. Arnold et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation
Miriam Hernangomez et al.
GLIA (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
Ngozi R. Monu et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Long-term infliximab maintenance therapy for ulcerative colitis: The ACT-1 and-2 extension studies
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2012)
Psychopharmacology of the endocannabinoids: far beyond anandamide
F. A. Pamplona et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
Ferdinando A. Giannone et al.
LABORATORY INVESTIGATION (2012)
IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes
Marzia Rossato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10-/- mice by attenuating the activation of T cells and promoting their apoptosis
Udai P. Singh et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
Athanasios Lourbopoulos et al.
BRAIN RESEARCH (2011)
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Ewa Kozela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Endocannabinoids in Liver Disease
Joseph Tam et al.
HEPATOLOGY (2011)
Microbiota Downregulates Dendritic Cell Expression of miR-10a, Which Targets IL-12/IL-23p40
Xiaochang Xue et al.
JOURNAL OF IMMUNOLOGY (2011)
Cannabinoid Neuroimmune Modulation of SIV Disease
Patricia E. Molina et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
Venkatesh L. Hegde et al.
PLOS ONE (2011)
The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
J. M. Jamontt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
Venkatesh L. Hegde et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Sadiye Amcaoglu Rieder et al.
IMMUNOBIOLOGY (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Current Management of Pain Associated with Multiple Sclerosis
Walter Pöllmann et al.
CNS DRUGS (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons
Ning Qin et al.
JOURNAL OF NEUROSCIENCE (2008)
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory T cells
Venkatesh L. Hegde et al.
MOLECULAR PHARMACOLOGY (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity
Anne R. Gocke et al.
JOURNAL OF IMMUNOLOGY (2007)
CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: Potential role for CB2-selective ligands as immunosuppressive agents
Catherine Lombard et al.
CLINICAL IMMUNOLOGY (2007)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
The pharmacology of cannabinoid receptors and their ligands: an overview
RG Pertwee
INTERNATIONAL JOURNAL OF OBESITY (2006)
Further characterization of the time-dependent vascular effects of Δ9-tetrahydrocannabinol
SE O'Sullivan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
E Eljaschewitsch et al.
NEURON (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
SB Hanauer
INFLAMMATORY BOWEL DISEASES (2006)
P38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells
B Herrera et al.
FEBS LETTERS (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
B Costa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis:: Novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do et al.
JOURNAL OF IMMUNOLOGY (2004)
Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes
AE Lovett-Racke et al.
IMMUNITY (2004)
A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells
MI Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased expression of interleukin 17 in inflammatory bowel disease
S Fujino et al.
GUT (2003)
Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
M Yuan et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
TG del Pulgar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid
A Porcella et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Δ9-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo
RJ McKallip et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Molecular biology of cannabinoid receptors
B Lutz
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
SJ Carlisle et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Cannabinoids for control of chemotherapy induced nausea and vomiting:: quantitative systematic review
MR Tramèr et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells
DI Gabrilovich et al.
JOURNAL OF IMMUNOLOGY (2001)
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus
P Derkinderen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase
D Rueda et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
